Unknown

Dataset Information

0

Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma.


ABSTRACT: Classical Hodgkin lymphoma is biologically different than other lymphomas. The cancer cells only occupy a small amount of the lymph node and evade the immune system by amplification of PD-L1 and PD-L2. Therefore, checkpoint inhibitors are a logical treatment option for Hodgkin lymphoma patients to unlock the immune system. Checkpoint inhibitors have shown high response rates in clinical trials in advanced-stage Hodgkin lymphoma. The two most commonly used checkpoint inhibitors are pembrolizumab and nivolumab, both FDA approved as third-line therapy. There is increasing interest in the use of checkpoint inhibitors with combination chemotherapy or with other targeted agents in the second-line or even frontline setting. In this review, we will highlight the clinical trials that led to approvals of checkpoint inhibitors for Hodgkin lymphoma.

SUBMITTER: Lin AY 

PROVIDER: S-EPMC8882667 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma.

Lin Adam Yuh AY   Schnitter Joseph Michael JM   Gordon Leo I LI  

ImmunoTargets and therapy 20220223


Classical Hodgkin lymphoma is biologically different than other lymphomas. The cancer cells only occupy a small amount of the lymph node and evade the immune system by amplification of PD-L1 and PD-L2. Therefore, checkpoint inhibitors are a logical treatment option for Hodgkin lymphoma patients to unlock the immune system. Checkpoint inhibitors have shown high response rates in clinical trials in advanced-stage Hodgkin lymphoma. The two most commonly used checkpoint inhibitors are pembrolizumab  ...[more]

Similar Datasets

| S-EPMC7288660 | biostudies-literature
| S-EPMC5728646 | biostudies-literature
| S-EPMC6745954 | biostudies-literature
| S-EPMC7432396 | biostudies-literature
| S-EPMC11283877 | biostudies-literature
| S-EPMC6025119 | biostudies-literature
| S-EPMC4910761 | biostudies-literature
| S-EPMC6530161 | biostudies-literature
| S-EPMC9310712 | biostudies-literature
| S-EPMC7734213 | biostudies-literature